Biogena Group Invest AG Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022
Net Income	0.33	0.18	0.3	0.82
Changes in Inventories	-	-	0.08	-1.04
Changes in Accounts Payable	-	-	0.05	-0.02
Changes in Accrued Expenses	-	-	0	0
Changes in Income Taxes Payable	-0	-0	-0.03	-0.05
Changes in Other Operating Activities	-0.14	-0.17	-	-
Operating Cash Flow	-0.01	0.03	0.41	-0.29
Operating Cash Flow Growth	-	-93.84%	-	-
Purchases of Investments	-	-	0	-5.61
Investing Cash Flow	0.14	0.17	0	-5.61
Issuance of Common Stock	-	-	0	5.79
Net Common Stock Issued (Repurchased)	-	-	0	5.79
Common Dividends Paid	-	-	-0.4	-0.08
Financing Cash Flow	-0.12	-0.2	-0.4	5.71
Net Cash Flow	-0.01	-0	0.01	-0.19
Free Cash Flow	-0.01	0.03	0.41	-0.29
Free Cash Flow Growth	-	-93.84%	-	-
FCF Margin	-0.00%	0.02%	0.16%	-0.09%
Free Cash Flow Per Share	-0.00	0.01	0.10	-0.07
Levered Free Cash Flow	330.13	172.23	298.3	734.16
Unlevered Free Cash Flow	197.54	3.33	92.18	-69.38